TRANSGENE (EPA:TNG) | WebDisclosure

PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 4 months ago

Transgene franchit des étapes clés en 2024, avec la preuve de principe clinique de son vaccin individualisé contre le cancer ? Perspectives prometteuses pour 2025
Transgene publie ses résultats annuels 2024 et fait le point sur son activité, notamment la preuve de principe clinique de son vaccin individualisé contre le cancer. Perspectives prometteuses pour 2025

Résultats Annuels Perspectives Cancer Transgene Vaccin Thérapeutique
PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 4 months ago

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ? Strong Outlook for 2025
Transgene achieves key milestones in 2024, including clinical proof of principle for individualized cancer vaccine TG4050, with strong outlook for 2025. New trial planned in Q4 2025 for a second indication

Milestones Cancer Vaccine Transgene 2025 Outlook Clinical Proof
BRIEF

published on 01/21/2025 at 17:50, 1 year 6 months ago

Transgene se prépare pour le Biomed Forum des investisseurs

Investisseurs BIOMED Forum Immunothérapie Transgene Vecteurs Viraux
BRIEF

published on 01/21/2025 at 17:50, 1 year 6 months ago

Transgene Prepares for Biomed Investor Forum

Investors BIOMED Forum Immunotherapy Transgene Viral Vectors
PRESS RELEASE

published on 01/21/2025 at 17:45, 1 year 6 months ago

Transgene participera à la conférence investisseurs Biomed Forum
Transgene participera à la conférence investisseurs Biomed Forum le 4 février 2025. Présentation de ses immunothérapies contre le cancer reposant sur des vecteurs viraux

BIOMED Forum Immunothérapie Cancer Transgene Vecteurs Viraux
PRESS RELEASE

published on 01/21/2025 at 17:45, 1 year 6 months ago

Transgene to Participate in the Biomed Forum Investor Conference
Transgene's management team to participate in the Biomed Forum Investor Conference in Paris on February 4, 2025

Investor Conference Paris BIOMED Forum Transgene February 4
BRIEF

published on 11/05/2024 at 07:35, 1 year 9 months ago

Transgene et ProBioGen unissent leurs forces pour les vaccins anti-cancer personnalisés

Biotechnologie Cancer Transgene ProBioGen Vaccins Personnalisés
BRIEF

published on 11/05/2024 at 07:35, 1 year 9 months ago

Transgene and ProBioGen join forces for personalized cancer vaccines

Biotechnology Cancer Transgene ProBioGen Personalized Vaccines
PRESS RELEASE

published on 11/05/2024 at 07:30, 1 year 9 months ago

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés
Transgene et ProBioGen collaborent pour développer les vaccins thérapeutiques individualisés, annoncent un accord de licence pour la lignée cellulaire AGE1.CR.pIX®

Transgene Vaccins ProBioGen Thérapeutiques Lignée Cellulaire
PRESS RELEASE

published on 10/14/2024 at 07:30, 1 year 10 months ago

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers

Published on 08/20/2026 at 02:22, 25 minutes ago

Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 01:00, 1 hour 47 minutes ago

Irving Resources Announces Results of AGM
Published on 08/20/2026 at 00:40, 2 hours 7 minutes ago

Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 4 hours 47 minutes ago

Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 6 hours 12 minutes ago

Revive Therapeutics Announces Proposed Shares for Debt Settlement

View all ACCESSWIRE

Published on 08/20/2026 at 01:45, 1 hour 1 minute ago

EQS-Adhoc: Dexus Finance Pty Limited: 2026 Annual results – Delivers on guidance and progresses key strategic actions
Published on 08/20/2026 at 01:37, 1 hour 10 minutes ago

Exchangeable Notes - Notes to Noteholders
Published on 08/19/2026 at 18:45, 8 hours 2 minutes ago

NNS acquires shares in OCI
Published on 08/19/2026 at 18:00, 8 hours 47 minutes ago

Dividend Declaration
Published on 08/19/2026 at 17:37, 9 hours 9 minutes ago

Monthly Performance Factsheet

View all EQS

Published on 08/18/2026 at 18:00, 1 day 8 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 9 hours ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 15 hours ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 15 hours ago

GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 7 hours ago

Aéroports de Paris S.A - July 2026 traffic figures

View all LES ECHOS COMFI WIRE

News